Table 1 Anti-proliferative activity of Cisplatin (IV) prodrugs. Anti-proliferative activity was determined according to Materials and Methods. IC₅₀s values of the different derivatives are in microM. Data shown are of representative experiment with CV below 15 % in all samples. Experiment was repeated three times with comparable outcome

From: Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study